Signia Pure C&G IX Expert Review

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 4.00/5, ranking #19 among 35 prescription hearing aids tested.

This device demonstrates consistent strengths across our measurement framework. Speech in Quiet performance is strong at 4.1/5, measuring +0.67 points above the category average. Speech in Noise scores 2.3/5—above the category average by +0.77 points, though only mixed in absolute terms. Feedback handling is excellent at 5.0/5, and own-voice comfort is solid at 3.2/5, sitting +0.47 points above average.

The Pure C&G IX shows meaningful improvement with professional fitting. The normalized Initial Score of 3.8/5 increases to 4.5/5 after tuning—a +0.7 point gain achieved while maintaining the same vented sleeve coupling. This suggests the device responds well to optimization without requiring more occluding domes.

At this premium price point, several alternatives in the same range scored higher in our testing, including the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5). The Pure C&G IX offers reliable performance with rechargeable batteries and streaming for both iPhone and Android, making it suitable for users who prioritize stable feedback control and want a device that improves substantially with professional fitting.